Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
Byondis B.V.
Nicholas Turner; Cristina Saura; Philippe Aftimos; Evelyn van den Tweel; Mayke Oesterholt; Norbert Koper; Marco Colleoni; Emilie Kaczmarek; Kevin Punie; Xinni Song; Anne Armstrong; Giulia Bianchi; Agostina Stradella; Sylvain Ladoire; Joline Si Jing Lim; Nathalie Quenel-Tueux; Tira J Tan; Santiago Escrivá-de-Romaní; Joyce O'Shaughnessy; TULIP Trial Investigators